A detailed history of Financial Gravity Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 5,680 shares of ABT stock, worth $675,636. This represents 0.15% of its overall portfolio holdings.

Number of Shares
5,680
Previous 320 1675.0%
Holding current value
$675,636
Previous $35.3 Million 1573.97%
% of portfolio
0.15%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$100.73 - $112.44 $539,912 - $602,678
5,360 Added 1675.0%
5,680 $590 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $99,882 - $110,315
912 Added 18.91%
5,736 $652 Million
Q4 2023

Jun 26, 2024

SELL
$90.19 - $110.4 $488,469 - $597,926
-5,416 Reduced 94.42%
320 $35.2 Million
Q3 2023

Nov 15, 2023

BUY
$95.53 - $114.62 $435,425 - $522,437
4,558 Added 1713.53%
4,824 $467,000
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $806 - $898
8 Added 3.1%
266 $3.9 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $14,335 - $16,873
148 Added 134.55%
258 $316,000
Q4 2022

Feb 15, 2023

SELL
$95.06 - $111.52 $44,868 - $52,637
-472 Reduced 81.1%
110 $3.1 Million
Q3 2022

Nov 03, 2022

SELL
$96.76 - $112.03 $6,966 - $8,066
-72 Reduced 11.01%
582 $276,000
Q2 2022

Aug 05, 2022

SELL
$102.07 - $123.37 $8,880 - $10,733
-87 Reduced 11.74%
654 $310,000
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $18,813 - $22,941
-165 Reduced 18.21%
741 $343,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $97,391 - $119,250
843 Added 1338.1%
906 $409,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $8,399 - $9,292
-72 Reduced 53.33%
63 $125,000
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $423 - $498
-4 Reduced 2.88%
135 $131,000
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $9,904 - $11,668
-91 Reduced 39.57%
139 $798,000
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $24,150 - $26,316
230 New
230 $25,000
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $90,658 - $116,032
-1,184 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $68,725 - $100,494
-1,094 Reduced 48.02%
1,184 $93,000
Q4 2019

Feb 28, 2020

SELL
$78.51 - $87.4 $72,700 - $80,932
-926 Reduced 28.9%
2,278 $198,000
Q3 2019

Oct 15, 2019

SELL
$81.84 - $88.74 $156,887 - $170,114
-1,917 Reduced 37.43%
3,204 $268,000
Q2 2019

Jul 26, 2019

BUY
$72.88 - $85.0 $220,607 - $257,295
3,027 Added 144.56%
5,121 $431,000
Q1 2019

Apr 19, 2019

BUY
$66.22 - $80.06 $90,787 - $109,762
1,371 Added 189.63%
2,094 $167,000
Q3 2018

Oct 31, 2018

SELL
$60.81 - $73.36 $59,168 - $71,379
-973 Reduced 57.37%
723 $49,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $95,508 - $105,412
1,659 Added 4483.78%
1,696 $109,000
Q1 2018

May 23, 2018

BUY
$56.27 - $63.62 $2,081 - $2,353
37 New
37 $2,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.